A recent study has demonstrated that administration of sPD-L1 in mice with ARDS alleviated inflammatory lung damage and improved survival rate by decreasing the number of lung monocyte-derived macrophages and their pro-inflammatory markers [40]. The gene discussed is SPDL1; the disease is acute respiratory distress syndrome.